Literature DB >> 15939755

CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.

Dean T Nardelli1, Joseph P Cloute, K H Kevin Luk, Jose Torrealba, Thomas F Warner, Steven M Callister, Ronald F Schell.   

Abstract

CD4(+) CD25(+) T cells are a population of regulatory T cells associated with control of arthritis in anti-interleukin-17 antibody-treated Borrelia-vaccinated and challenged gamma interferon-deficient mice. Here, we present direct evidence that adoptive transfer of enriched CD4(+) CD25(+) T cells from these mice can prevent the development of arthritis in Borrelia-vaccinated and challenged mice. These findings establish a major role for CD4(+) CD25(+) T cells in the prevention of arthritis in Borrelia-vaccinated and challenged animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939755      PMCID: PMC1151965          DOI: 10.1128/CDLI.12.6.786-792.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  33 in total

1.  CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells.

Authors:  L Cederbom; H Hall; F Ivars
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

Review 2.  Regulatory T cells in the control of immune pathology.

Authors:  K J Maloy; F Powrie
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

3.  Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.

Authors:  Andre van van Maurik; Manuela Herber; Kathryn J Wood; Nick D Jones
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

4.  CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice.

Authors:  Shohei Hori; Thiago L Carvalho; Jocelyne Demengeot
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

5.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

Authors:  J Shimizu; S Yamazaki; S Sakaguchi
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

6.  Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.

Authors:  Dean T Nardelli; Matthew A Burchill; Douglas M England; Jose Torrealba; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

7.  B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans.

Authors:  Claudia Montagnoli; Angela Bacci; Silvia Bozza; Roberta Gaziano; Paolo Mosci; Arlene H Sharpe; Luigina Romani
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 8.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

9.  The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.

Authors:  Veronika Szanya; Joerg Ermann; Cariel Taylor; Claire Holness; C Garrison Fathman
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

10.  CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.

Authors:  P A Taylor; R J Noelle; B R Blazar
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  14 in total

Review 1.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

2.  Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.

Authors:  Carrie E Lasky; Kara E Jamison; Darcie R Sidelinger; Carmela L Pratt; Guoquan Zhang; Charles R Brown
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

3.  Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.

Authors:  Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2006-08

4.  Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.

Authors:  Joseph Kuo; Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

5.  CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis.

Authors:  Brandon T Leader; Charmie Godornes; Wesley C VanVoorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

6.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

7.  Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.

Authors:  Nicholas J Kotloski; Dean T Nardelli; Sara Heil Peterson; Jose R Torrealba; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

8.  Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

Authors:  Sara Heil Peterson; Dean T Nardelli; Thomas F Warner; Steven M Callister; Jose R Torrealba; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

9.  Regulatory T Cells Contribute to Resistance against Lyme Arthritis.

Authors:  Emily M Siebers; Elizabeth S Liedhegner; Michael W Lawlor; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

Review 10.  Interplay between pathogenic Th17 and regulatory T cells.

Authors:  Mohamed Oukka
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.